NASDAQ: BMRA - Biomerica, Inc.

Rentabilität für sechs Monate: +88.91%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Biomerica, Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Biomerica, Inc.

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

weitere details
It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; Helicobacter pylori test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2005-01-03
ISIN US09061H3075
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.biomerica.com
Цена ао 0.5725
Preisänderung pro Tag: 0% (0.6215)
Preisänderung pro Woche: +1.65% (0.6114)
Preisänderung pro Monat: -20.08% (0.7777)
Preisänderung über 3 Monate: +100.48% (0.31)
Preisänderung über sechs Monate: +88.91% (0.329)
Preisänderung pro Jahr: -42.19% (1.075)
Preisänderung über 3 Jahre: -83.43% (3.75)
Preisänderung über 5 Jahre: -77.88% (2.8099)
Preisänderung seit Jahresbeginn: +113.57% (0.291)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 1.94 7
P/BV 1.6 8
P/E 0 0
EV/EBITDA -1.19 0
Gesamt: 5.63

Effizienz

Name Bedeutung Grad
ROA, % -50.43 0
ROE, % -65.28 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.131 10
Gesamt: 9.6

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -19.18 0
Rentabilität Ebitda, % 215.42 10
Rentabilität EPS, % 54.44 7
Gesamt: 6.2
Weitere Details

Institutionen Volumen Aktie, %
Granahan Investment Management LLC 1082672 6.44
Wasatch Advisors LP 953264 5.67
Vanguard Group Inc 609365 3.62
Russell Investments Group, Ltd. 201563 1.2
Potomac Capital Management, Inc. 167700 1
Blackrock Inc. 149707 0.89
Geode Capital Management, LLC 120784 0.72
Susquehanna International Group, LLP 75916 0.45
CapTrust Financial Advisors 58668 0.35
Perritt Capital Management, Inc. 42500 0.25



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Gary Lu CPA Principal Accounting Officer & CFO 260k 1981 (44 Jahr)
Ms. Lucy Liu Ph.D. Director of Manufacturing & Technical Operations N/A
Mr. Robert W. Carlson Chief Commercial Officer N/A
Mr. Zackary S. Irani CEO & Director 1966 (59 Jahre)
Mr. Allen C. Barbieri Executive Vice-Chairman of the Board & Corporate Secretary 1958 (67 Jahre)

Adresse: United States, Irvine. CA, 17571 Von Karman Avenue - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.biomerica.com